DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Kudo M, Ueshia K, Ikeda M, Torimura T, Tanabe N, Aikata H. et al.
Randomized, open label, multicenter, phase II trial comparing transarterial chemoembolization (TACE) plus sorafenib with TACE alone in patients with hepatocellular carcinoma (HCC): TACTICS trial.

J Clin Oncol 2018;
36 (suppl):4S Abstr 206

Bibliographische Angaben herunterladen

Aufrufen in: